Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.1K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

420
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

249
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

364
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

663
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

4.8K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and late results of mitral valve repair with anterior leaflet patch augmentation.

Interactive cardiovascular and thoracic surgery·2022
Same author

Pulmonary endarterectomy.

Indian journal of thoracic and cardiovascular surgery·2021
Same author

Creating a systemic national database-are we ready?

Indian journal of thoracic and cardiovascular surgery·2020
Same author

Veno-arterial extracorporeal membrane oxygenationas a bridge to cytolytic therapy.

Indian journal of thoracic and cardiovascular surgery·2020
Same author

Long-term patency of 1108 radial arterial-coronary angiograms over 10 years.

The Annals of thoracic surgery·2009
Same author

Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.

Interactive cardiovascular and thoracic surgery·2009

Related Experiment Video

Updated: Jan 28, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K

Fast-track off-pump coronary artery bypass: single-center experience.

Chirantan Mangukia1, Mehul Kachhadia1, Manish Meswani1

  • 1NM Virani Wockhardt Hospitals, Rajkot, Gujarat, India.

Asian Cardiovascular & Thoracic Annals
|February 26, 2019
PubMed
Summary

Identifying risk factors for prolonged hospital stay after fast-track coronary artery bypass grafting is crucial. Key predictors of fast-track failure include prolonged ventilation and major complications, with 90.2% survival at 66 months.

Keywords:
Anesthesiacardiac procedurescardiac surgical procedurescoronary artery bypassoff-pumprisk factorssurvival

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.9K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Related Experiment Videos

Last Updated: Jan 28, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.9K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Critical Care Medicine

Background:

  • Fast-track cardiac surgery protocols aim to reduce length of stay and improve patient outcomes.
  • Coronary artery bypass grafting (CABG) is a common cardiac surgical procedure.
  • Identifying factors influencing fast-track success is essential for optimizing patient care.

Purpose of the Study:

  • To conduct a retrospective analysis of fast-track CABG at our institution.
  • To identify risk factors associated with prolonged hospital stay after fast-track CABG.
  • To compare survival statistics with existing literature.

Main Methods:

  • Retrospective analysis of 709 patients undergoing fast-track CABG.
  • Patients had a mean age of 58.85 years, with 572 males.
  • Mean EuroSCORE II was 2.02%; 76% were discharged within 100 hours.

Main Results:

  • Prolonged ventilation/reintubation, pulmonary, gastrointestinal, and neurological complications were strong predictors of fast-track failure.
  • Other significant risk factors included atrial fibrillation, renal impairment, sternal wound infection, diabetes, preoperative balloon pump use, left ventricular dysfunction, and peripheral arterial disease.
  • Cumulative survival at 66 months was 90.2% ± 0.02%.

Conclusions:

  • Several factors significantly increase the risk of fast-track failure in CABG patients.
  • Smoking cessation can mitigate the impact of chronic obstructive pulmonary disease on fast-track outcomes.
  • Survival rates are comparable to those reported in the literature, supporting the efficacy of the protocol.